Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Oral Topotecan in Children With Relapsed Acute Leukemia

NCT00003735 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Oral Topotecan in Children With Relapsed Acute Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1998
Completion date
September 30, 2006
Enrollment
11 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia